These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 27742220)

  • 61. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis.
    Gupta G; Ali R; Khan AA; Rao DN
    Int Immunopharmacol; 2012 Jan; 12(1):64-73. PubMed ID: 22094541
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of the Yersinia enterocolitica 0:8 V antigen for cross protectivity.
    Schmidt A; Schaffelhofer S; Müller K; Röllinghoff M; Beuscher HU
    Microb Pathog; 1999 Apr; 26(4):221-33. PubMed ID: 10089162
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Replication-Defective Human Type 5 Adenovirus-Based Trivalent Vaccine Confers Complete Protection against Plague in Mice and Nonhuman Primates.
    Sha J; Kirtley ML; Klages C; Erova TE; Telepnev M; Ponnusamy D; Fitts EC; Baze WB; Sivasubramani SK; Lawrence WS; Patrikeev I; Peel JE; Andersson JA; Kozlova EV; Tiner BL; Peterson JW; McWilliams D; Patel S; Rothe E; Motin VL; Chopra AK
    Clin Vaccine Immunol; 2016 Jul; 23(7):586-600. PubMed ID: 27170642
    [TBL] [Abstract][Full Text] [Related]  

  • 65. N255 is a key residue for recognition by a monoclonal antibody which protects against Yersinia pestis infection.
    Hill J; Leary S; Smither S; Best A; Pettersson J; Forsberg A; Lingard B; Lipka A; Brown KA; Williamson ED; Titball RW
    Vaccine; 2009 Nov; 27(50):7073-9. PubMed ID: 19786138
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Oral immunization of a non-recombinant Lactococcus lactis surface displaying influenza hemagglutinin 1 (HA1) induces mucosal immunity in mice.
    Jee PF; Tiong V; Shu MH; Khoo JJ; Wong WF; Abdul Rahim R; AbuBakar S; Chang LY
    PLoS One; 2017; 12(11):e0187718. PubMed ID: 29108012
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Recombinant YopE and LcrV vaccine candidates protect mice against plague and yersiniosis.
    Gupta A; Mahajan P; Bhagyawant SS; Saxena N; Johri AK; Kumar S; Verma SK
    Heliyon; 2024 May; 10(10):e31446. PubMed ID: 38826713
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CCR2
    Zhang Y; Khairallah C; Sheridan BS; van der Velden AWM; Bliska JB
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263104
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cell-mediated immune response to epitopic MAP (multiple antigen peptide) construct of LcrV antigen of Yersinia pestis in murine model.
    Shreewastav RK; Ali R; Uppada JB; Rao DN
    Cell Immunol; 2012; 278(1-2):55-62. PubMed ID: 23121976
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunization with Chlamydia psittaci plasmid-encoded protein CPSIT_p7 induces partial protective immunity against chlamydia lung infection in mice.
    Tan Y; Li Y; Zhang Y; Yu J; Wen Y; Wang C; Xu M; Chen Q; Lu C; Wu Y
    Immunol Res; 2018 Aug; 66(4):471-479. PubMed ID: 30097797
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.
    Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X
    Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.
    Nakajima R; Motin VL; Brubaker RR
    Infect Immun; 1995 Aug; 63(8):3021-9. PubMed ID: 7622225
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Remodeling
    Wang X; Li P; Singh AK; Zhang X; Guan Z; Curtiss R; Sun W
    Proc Natl Acad Sci U S A; 2022 Mar; 119(11):e2109667119. PubMed ID: 35275791
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae.
    Sreerohini S; Balakrishna K; Parida M
    APMIS; 2019 Oct; 127(10):671-680. PubMed ID: 31344276
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oral vaccination against plague using Yersinia pseudotuberculosis.
    Demeure CE; Derbise A; Carniel E
    Chem Biol Interact; 2017 Apr; 267():89-95. PubMed ID: 27046452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.
    Sing A; Roggenkamp A; Geiger AM; Heesemann J
    J Immunol; 2002 Feb; 168(3):1315-21. PubMed ID: 11801671
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [The protective properties of a porin from the outer membrane of Yersinia pseudotuberculosis].
    Timchenko NF; Novikova OD; Pavlova TN; Venediktov VS; Solov'eva TF
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):48-50. PubMed ID: 1965874
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Broad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.
    Do Y; Park CG; Kang YS; Park SH; Lynch RM; Lee H; Powell BS; Steinman RM
    Eur J Immunol; 2008 Jan; 38(1):20-9. PubMed ID: 18081041
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Bacterium-like particles supplemented with inactivated influenza antigen induce cross-protective influenza-specific antibody responses through intranasal administration.
    de Haan A; Haijema BJ; Voorn P; Meijerhof T; van Roosmalen ML; Leenhouts K
    Vaccine; 2012 Jul; 30(32):4884-91. PubMed ID: 22537989
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.
    Sing A; Reithmeier-Rost D; Granfors K; Hill J; Roggenkamp A; Heesemann J
    Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16049-54. PubMed ID: 16239347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.